Overbought right now. Long over entry level
Has been large effective volume on this one th last few days according to Chartmill's indicator
C&H patterns are not valid unless entry level is reached
This is a weekly time frame cup and handle pattern in formation
No rising wedges
Not a recommendation.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. Personalis, Inc. has partnership with Berry Genomics. The company was founded in 2011 and is headquartered in Menlo Park, California.
Has been large effective volume on this one th last few days according to Chartmill's indicator
C&H patterns are not valid unless entry level is reached
This is a weekly time frame cup and handle pattern in formation
No rising wedges
Not a recommendation.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. Personalis, Inc. has partnership with Berry Genomics. The company was founded in 2011 and is headquartered in Menlo Park, California.
Comentarios:
Support at 24.79ish